The 2026 Nobel Prize in Physiology or Medicine went to Peter Hegemann of Humboldt University of Berlin, Georg Nagel of the University of Würzburg, and Karl Deisseroth of Stanford University, for work that turned a basic finding about algae into a tool for studying the brain. Hegemann and Nagel set out to understand how Chlamydomonas, a tiny single-celled alga, senses light, and found that a single protein called channelrhodopsin does the job. Light striking a small molecule inside the protein makes it change shape, opening a passage through the cell membrane that lets positively charged particles flow in and signal the alga to swim.
The link to neuroscience comes from how nerve cells work. Nerve cells control their activity using the movement of charged particles across their membranes, so the researchers realized that putting channelrhodopsin into nerve cells might allow them to switch those cells on with light. Deisseroth joined them in developing this idea into the field now called optogenetics.
In practice, scientists deliver the channelrhodopsin gene to the cells they want to study, usually using a virus that has been altered so it cannot cause disease. Once those cells make the protein, shining light on them activates only those cells, while nearby neurons without the protein are unaffected. In animals such as mice, light can be delivered through a thin optical fibre, and it can be aimed at very small areas and switched on and off quickly.
That precision has made optogenetics a powerful way to test what particular groups of nerve cells do. The source describes a 2012 experiment from the Massachusetts Institute of Technology, in which mice that had received a mild electric shock later froze when light reactivated the memory-related cells active during that shock, a result that Deisseroth co-authored. Optogenetics is also in early-stage clinical trials for people with retinal degeneration, where introducing light-sensitive proteins into surviving retinal cells may restore some vision, and researchers are investigating its potential for Parkinson's and epilepsy.
The source also makes a point about the value of basic questions. The work began with how algae swim toward light, a question with no obvious medical application at the time, and the article argues that this is exactly why such research matters, since it is impossible to predict where knowledge will lead.